• 1
    Jarai R, Wojta J, Huber K. Circulating B-type natriuretic peptides in patients with acute coronary syndromes. Pathophysiological, prognostical and therapeutical considerations. Thromb Haemost. 2005; 94: 92632.
  • 2
    Hall C. Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail. 2004; 6: 25760.
  • 3
    Tsuruda T, Boerrigter G, Huntley BK, et al . Brain natriuretic peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases. Circ Res. 2002; 91: 112734.
  • 4
    Manabe I, Shindo T, Nagai R. Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res. 2002; 91: 110313.
  • 5
    Bradham WS, Moe G, Wendt KA, et al . TNF-alpha and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling. Am J Physiol Heart Circ Physiol. 2002; 282: H128895.
  • 6
    Oral H, Sivasubramanian N, Dyke DB, et al . Myocardial proinflammatory cytokine expression and left ventricular remodeling in patients with chronic mitral regurgitation. Circulation. 2003; 107: 8317.
  • 7
    Lim H, Zhu YZ. Role of transforming growth factor-beta in the progression of heart failure. Cell Mol Life Sci. 2006; 63: 258496.
  • 8
    Chen D, Assad-Kottner C, Orrego C, et al . Cytokines and acute heart failure. Crit Care Med. 2008; 36: S916.
  • 9
    Wiesbauer F, Kaun C, Zorn G, et al . HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins. Br J Pharmacol. 2002; 135: 28492.
  • 10
    Weiss TW, Kvakan H, Kaun C, et al . The gp130 ligand oncostatin M regulates tissue inhibitor of metalloproteinases-1 through ERK1/2 and p38 in human adult cardiac myocytes and in human adult cardiac fibroblasts: a possible role for the gp130/gp130 ligand system in the modulation of extracellular matrix degradation in the human heart. J Mol Cell Cardiol. 2005; 39: 54551.
  • 11
    Weiss TW, Speidl WS, Kaun C, et al . Glycoprotein 130 ligand oncostatin-M induces expression of vascular endothelial growth factor in human adult cardiac myocytes. Cardiovasc Res. 2003; 59: 62838.
  • 12
    Kapoun AM, Liang F, O’Young G, et al . B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation, and inflammation. Circ Res. 2004; 94: 45361.
  • 13
    Harada E, Nakagawa O, Yoshimura M, et al . Effect of interleukin-1 beta on cardiac hypertrophy and production of natriuretic peptides in rat cardiocyte culture. J Mol Cell Cardiol. 1999; 31: 19972006.
  • 14
    Node K, Fujita M, Kitakaze M, et al . Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy. Circulation. 2003; 108: 83943.
  • 15
    Khush KK, Waters DD, Bittner V, et al . Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) Study. Circulation. 2007; 115: 57683.
  • 16
    Smit JW, Wijnne HJ, Schobben F, et al . Effects of alcohol and fluvastatin on lipid metabolism and hepatic function. Ann Intern Med. 1995; 122: 67880.
  • 17
    Rikitake Y, Liao JK. Rho GTPases, statins, and nitric oxide. Circ Res. 2005; 97: 12325.
  • 18
    Shiga N, Hirano K, Hirano M, et al . Long-term inhibition of RhoA attenuates vascular contractility by enhancing endothelial NO production in an intact rabbit mesenteric artery. Circ Res. 2005; 96: 101421.
  • 19
    Laufs U, Liao JK. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem. 1998; 273: 2426671.
  • 20
    Degraeve F, Bolla M, Blaie S, et al . Modulation of COX-2 expression by statins in human aortic smooth muscle cells. Involvement of geranylgeranylated proteins. J Biol Chem. 2001; 276: 4684955.
  • 21
    He Q, LaPointe MC. Interleukin-1beta regulation of the human brain natriuretic peptide promoter involves Ras-, Rac-, and p38 kinase-dependent pathways in cardiac myocytes. Hypertension. 1999; 33: 2839.
  • 22
    Tanimoto A, Murata Y, Wang KY, et al . Monocyte chemoattractant protein-1 expression is enhanced by granulocyte-macrophage colony-stimulating factor via Jak2-Stat5 signaling and inhibited by atorvastatin in human monocytic U937 cells. J Biol Chem. 2008; 283: 464351.
  • 23
    Wang TN, Ge YK, Li JY, et al . B-type natriuretic peptide enhances mild hypoxia-induced apoptotic cell death in cardiomyocytes. Biol Pharm Bull. 2007; 30: 108490.
  • 24
    Kogler H, Schott P, Toischer K, et al . Relevance of brain natriuretic peptide in preload-dependent regulation of cardiac sarcoplasmic reticulum Ca2+ ATPase expression. Circulation. 2006; 113: 272432.
  • 25
    Zhang Q, Moalem J, Tse J, et al . Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling. Eur J Pharmacol. 2005; 510: 20915.
  • 26
    Goukassian DA, Qin G, Dolan C, et al . Tumor necrosis factor-alpha receptor p75 is required in ischemia-induced neovascularization. Circulation. 2007; 115: 75262.
  • 27
    Vellaichamy E, Kaur K, Pandey KN. Enhanced activation of pro-inflammatory cytokines in mice lacking natriuretic peptide receptor-A. Peptides. 2007; 28: 8939.
  • 28
    Kawakami R, Saito Y, Kishimoto I, et al . Overexpression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase-9 expression after acute myocardial infarction. Circulation. 2004; 110: 330612.
  • 29
    Dejam A, Hunter CJ, Tremonti C, et al . Nitrite infusion in humans and nonhuman primates. Endocrine effects, pharmacokinetics, and tolerance formation. Circulation. 2007; 116: 182131.
  • 30
    Erusalimsky JD, Moncada S. Nitric oxide and mitochondrial signaling. From physiology to pathophysiology. Arterioscler Thromb Vasc Biol. 2007; 27: 252431.
  • 31
    Cosby K, Partovi KS, Crawford JH, et al . Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med. 2003; 9: 1498505.
  • 32
    Van Der Zander K, Houben AJ, Kroon AA, et al . Nitric oxide and potassium channels are involved in brain natriuretic peptide induced vasodilatation in man. J Hypertens. 2002; 20: 4939.
  • 33
    Gissi-HFI  . Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008; 372: 12319.